Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Who we are

We are an innovation-led contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply.

What we do

We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements. Our approach enables us to forge client relationships that move beyond the traditional service outsourcing model into true end-to-end collaborations.

Discovery

Our Discovery Services span the entire spectrum of early stage research from target …

Development

Our Development Services encompass activities from pre-clinical to clinical trials…

Manufacturing

Our Manufacturing services include cGMP-compliant facilities for clinical supplies, registration batches…

Dedicated Centers

Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support…

InstaVisit – Visit Syngene virtually

Syngene InstaVisit is an interactive virtual experience designed to give you a 360 degree view of Syngene’s world-class facilities and capabilities. The platform allows you to change your perspective, look around and zoom in as we take you on a guided tour of Syngene’s labs.

Visit Syngene virtually with a 360 degree view of Syngene’s world-class facilities and capabilities
0 +

Active Clients

0

Collaborations with top 20 Pharma/Biotech companies

5200 +

Scientists

0

Mn sq. ft. of R&D and manufacturing infrastructure

0 +

Patents 

Syngene Expects Biz to Pick Up by H2 on Funding Revival

News
19th Jun, 2024

Syngene announces second year of STEM scholarship and mentorship program for women in collaboration with RICH

Press Release
18th Jun, 2024

Biosecurity threats and business as usual

News
9th Jun, 2024

Innovation at Syngene: Translatable models for improving cancer research

Syngene scientists have developed orthotopic and spheroid tumor models, which can help improve translatability and clinical relevance for cancer research.

pDNA and mRNA manufacturing in the age of Precision Therapies: The role of CDMOs

Challenges in pDNA manufacturing and why CDMOs are best suited for supplying pDNA for Precision Therapies.

Leveraging High Throughput Screening services to accelerate drug discovery and development

The many applications of HTS and how it has evolved beyond lead identification and candidate optimization today.

Upcoming events

19th to 21st June
Shanghai
25th June
USA
26th to 28th June
Tokyo
2nd & 3rd July
Montpellier, France
25th to 28th July
Taiwan
27th to 29th August
Seoul, South Korea

Corporate Social Responsibility

To strive towards developing and sustaining healthy and empowered communities by improving the quality of life.

Governance

Behind consistent growth is good governance

Careers

Discover a world of opportunities

Annual Reports

Touching a billon lives through innnovation

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details